Another study found that loss of SETD2 led to down-regulated expression of the tumor suppressor ASXL1 (Additional Sex Combs-Like protein 1) and an upregulation of ERG, resulting in accelerated leukemia development [39]. The gene discussed is ASXL1; the disease is leukemia.